• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Orion Corporation - Articles and news items

BAY-1841788

Bayer and Orion expand BAY-1841788 programme in prostate cancer

Industry news / 3 June 2016 / Victoria White, Digital Content Producer

The Phase III study ARASENS will evaluate BAY-1841788 in men with newly diagnosed metastatic hormone-sensitive prostate cancer…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +